The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

Study Published in a special issue of International Journal of Molecular Sciences Confirms Test's Ability to Distinguish ...

A recent study has uncovered an unexpected connection between our diets and the progression of lung cancer, specifically a ...

The U.S. Food and Drug Administration (FDA) on Monday cleared the amendment to Lantern Pharma Inc.’s (NASDAQ:LTRN) ...

The new screening panel offers gender-specific diagnostics and hereditary risk assessment aimed at improving early cancer ...

OncoHost has won a €2.5m ($2.8m) grant to develop a novel biomarker capable of predicting cancer patient responses to immunotherapy.

Cancer care has changed dramatically over the last decade. As opposed to a "one-size-fits-all" approach, treatment today is ...

Grey’s Anatomy star Kate Walsh is partnering with GRAIL to advocate for more multi-cancer early detection testing in a ...

The initial finding was the start of a harrowing months-long ordeal to figure out what the mass was, including a biopsy that ...

The research, titled “Clinical Validation of Plasma Metabolite Markers for Early Lung Cancer Detection,” demonstrated the ...

Randee’s cancer had metastasized. When her doctor tested her for the PIK3CA gene mutation, she was able to make informed ...